Dnano Metabio has developed world leading drug delivery systems based on DNA/RNA materials   to address the unmet medical needs of tumors, infectious diseases, rare disease, etc. In previous studies, we have confirmed the organism targeting ability of our systems in murine models, especially tissue-specificity outside the liver.

Dnano MetaBio is engaged in partnership discussions with potential collaborators on the intelligent delivery of siRNA, mRNA, ASOs, gene editing constructs, and small drug molecules, bringing our new delivery platforms from the lab to the patients.